What is COO (COO) stock price today?

COO (COO) is currently trading at $69.73, up 0.65% today.

What is COO P/E ratio?

COO's P/E ratio is 59.40. This is above the market average, reflecting high growth expectations.

What is COO return on equity (ROE)?

COO's return on equity (ROE) is 2.84%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is COO's market cap?

COO has a market capitalization of $13.60B.

NASDAQ · Medical - Instruments & Supplies

COO (COO) Stock

$69.73 +0.65% NASDAQ: COO Healthcare

Valuation

Metric	Value
Price	$69.73
Market Cap	$13.60B
P/E Ratio	59.40
P/B Ratio	1.66
P/S Ratio	3.23
EPS (TTM)	$0.00
52-Week High	$89.83
52-Week Low	$58.89
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	2.84%
ROA	1.89%
ROCE	4.66%
Gross Margin	64.24%
Operating Margin	17.19%
Net Margin	5.57%
Debt/Equity	0.30
Current Ratio	1.89

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$2.9B	$3.3B	$3.6B	$3.9B	$4.1B
Operating Profit	$506.0M	$508.0M	$533.0M	$706.0M	$683.0M
Net Profit	$2.9B	$386.0M	$294.0M	$392.0M	$375.0M
EPS	$59.07	$1.94	$1.48	$1.96	$1.87
Op Margin	17.3%	15.3%	14.8%	18.1%	16.7%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$9.6B	$11.5B	$11.7B	$12.3B	$12.4B
Total Liabilities	$2.7B	$4.3B	$4.1B	$4.2B	$4.2B
Cash	$96.0M	$138.0M	$121.0M	$108.0M	$111.0M
Borrowings	$1.5B	$2.8B	$2.6B	$2.6B	$2.8B

Latest News

COO: Lowering target price to $75.00 Argus Research · Jul 15, 2026 Goldman Sachs Adjusts Price Target on Cooper Companies to $63 From $66, Maintains Sell Rating MT Newswires · Jul 14, 2026 2 Momentum Stocks to Consider Right Now and 1 We Turn Down StockStory · Jul 3, 2026 CooperCompanies Releases 2025 Corporate Sustainability Report with Scope 3 Emissions Disclosure GlobeNewswire · Jun 30, 2026 How COO Is Balancing Premium Lens Growth Against Asia-Pacific Risks? Zacks · Jun 30, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$739.0M	$692.0M	$608.0M	$709.0M	$796.0M
Investing Cash Flow	$-665.0M	$-2.1B	$-841.0M	$-1.2B	$-735.0M
Financing Cash Flow	$-25.0M	$-98.0M	$-13.0M	$-30.0M	$-362.0M
Net Cash Flow	$-20.0M	$42.0M	$-18.0M	$-13.0M	$3.0M
Free Cash Flow	$524.0M	$450.0M	$215.0M	$288.0M	$434.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	-1.37
EV / EBITDA	18.47
FCF Yield	4.17%
Quick Ratio	0.78
Interest Coverage	5.35
Return 1Y	6.74%
Return 3Y	-23.52%
Return 5Y	-38.80%

Ownership

Insiders Held0.61%

Institutions Held106.74%

Institutions Float Held107.40%

Institutional Holder	Shares	Report Date
Blackrock Inc.	16,618,129	2026-03-31
Vanguard Capital Management LLC	12,718,829	2026-03-31
T. Rowe Price Investment Management, Inc.	9,060,177	2026-03-31
State Street Corporation	8,768,419	2026-03-31
Vanguard Portfolio Management LLC	8,721,331	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
DOCS	$26.32	-0.11%	19.65	$4.92B	0.00%
FMSFresenius Medical Care AG & Co. KGaA	$23.69	-1.86%	12.64	$12.72B	3.63%
HOLXHologic, Inc.	$76.01	+0.00%	31.28	$16.97B	0.00%
ICLR	$159.84	-0.97%	11.92	$12.24B	0.00%
NBIX	$157.79	+0.66%	21.78	$15.87B	0.00%

About COO

COO is led by CEO Albert G. White, employs 15,000 people, headquartered in San Ramon, US, publicly traded since 1983.

COO stock trades at $69.73 with a market capitalization of $13.60B. The stock is valued at a price-to-earnings (P/E) ratio of 59.40, price-to-book of 1.66, price-to-sales of 3.23. Over the past 52 weeks the stock has ranged between $58.89 and $89.83, and currently trades 22.4% below its 52-week high.

On profitability, COO generates a return on equity (ROE) of 2.84%, return on capital employed of 4.66%, an operating margin of 17.19%, a net profit margin of 5.57%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides